betaine has been researched along with Renal Insufficiency, Chronic in 11 studies
glycine betaine : The amino acid betaine derived from glycine.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Some studies on CKD animal models have shown the benefits of betaine supplementation, including decreased kidney damage, antioxidant recovery status, and decreased inflammation." | 5.22 | The Role of Betaine in Patients With Chronic Kidney Disease: a Narrative Review. ( Alvarenga, L; Ferreira, MS; Kemp, JA; Mafra, D, 2022) |
| "Hyperhomocysteinemia has undoubtedly a central role in such a prominent cardiovascular burden." | 2.66 | Vitamin B Supplementation and Nutritional Intake of Methyl Donors in Patients with Chronic Kidney Disease: A Critical Review of the Impact on Epigenetic Machinery. ( Bergamini, C; Capelli, I; Cappuccilli, M; Cianciolo, G; Conte, D; Donati, G; Giacomelli, FA; La Manna, G; Natali, T, 2020) |
| "In end-stage renal disease (ESRD), these same small molecules are used to determine dialysis dose and dialytic clearance." | 1.51 | Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function. ( Garg, AX; House, AA; Lajoie, GA; Mio, MA; RaoPeters, AAE; Thomson, BKA; Tonial, NC; Urquhart, BL; Velenosi, TJ, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 7 (63.64) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, JA | 1 |
| Jewell, DE | 2 |
| Ephraim, E | 2 |
| Alvarenga, L | 1 |
| Ferreira, MS | 1 |
| Kemp, JA | 1 |
| Mafra, D | 1 |
| Kwan, B | 1 |
| Fuhrer, T | 1 |
| Montemayor, D | 1 |
| Fink, JC | 1 |
| He, J | 1 |
| Hsu, CY | 1 |
| Messer, K | 1 |
| Nelson, RG | 1 |
| Pu, M | 1 |
| Ricardo, AC | 1 |
| Rincon-Choles, H | 1 |
| Shah, VO | 1 |
| Ye, H | 1 |
| Zhang, J | 1 |
| Sharma, K | 1 |
| Natarajan, L | 1 |
| Pelletier, CC | 1 |
| Croyal, M | 1 |
| Ene, L | 1 |
| Aguesse, A | 1 |
| Billon-Crossouard, S | 1 |
| Krempf, M | 1 |
| Lemoine, S | 1 |
| Guebre-Egziabher, F | 1 |
| Juillard, L | 1 |
| Soulage, CO | 1 |
| Cappuccilli, M | 1 |
| Bergamini, C | 1 |
| Giacomelli, FA | 1 |
| Cianciolo, G | 1 |
| Donati, G | 1 |
| Conte, D | 1 |
| Natali, T | 1 |
| La Manna, G | 1 |
| Capelli, I | 1 |
| Guo, F | 1 |
| Dai, Q | 1 |
| Zeng, X | 1 |
| Liu, Y | 1 |
| Tan, Z | 1 |
| Zhang, H | 1 |
| Ouyang, D | 1 |
| Ebert, T | 1 |
| Painer, J | 1 |
| Bergman, P | 2 |
| Qureshi, AR | 2 |
| Giroud, S | 1 |
| Stalder, G | 1 |
| Kublickiene, K | 1 |
| Göritz, F | 1 |
| Vetter, S | 1 |
| Bieber, C | 1 |
| Fröbert, O | 1 |
| Arnemo, JM | 1 |
| Zedrosser, A | 1 |
| Redtenbacher, I | 1 |
| Shiels, PG | 1 |
| Johnson, RJ | 1 |
| Stenvinkel, P | 2 |
| Xu, KY | 1 |
| Xia, GH | 1 |
| Lu, JQ | 1 |
| Chen, MX | 1 |
| Zhen, X | 1 |
| Wang, S | 1 |
| You, C | 1 |
| Nie, J | 1 |
| Zhou, HW | 1 |
| Yin, J | 1 |
| Velenosi, TJ | 1 |
| Thomson, BKA | 1 |
| Tonial, NC | 1 |
| RaoPeters, AAE | 1 |
| Mio, MA | 1 |
| Lajoie, GA | 1 |
| Garg, AX | 1 |
| House, AA | 1 |
| Urquhart, BL | 1 |
| Missailidis, C | 1 |
| Hällqvist, J | 1 |
| Barany, P | 1 |
| Heimbürger, O | 1 |
| Lindholm, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Washed Microbiota Transplantation (WMT) for Chronic Kidney Disease (CKD): a Open Label, Multicenter Trial[NCT05838118] | 100 participants (Anticipated) | Interventional | 2023-04-20 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for betaine and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
The Role of Betaine in Patients With Chronic Kidney Disease: a Narrative Review.
Topics: Animals; Antioxidants; Betaine; Dysbiosis; Humans; Inflammation; Renal Insufficiency, Chronic | 2022 |
Vitamin B Supplementation and Nutritional Intake of Methyl Donors in Patients with Chronic Kidney Disease: A Critical Review of the Impact on Epigenetic Machinery.
Topics: Betaine; Cardiovascular Diseases; Choline; Dietary Supplements; DNA Methylation; Eating; Epigenesis, | 2020 |
1 trial available for betaine and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Betaine and Soluble Fiber Improve Body Composition and Plasma Metabolites in Cats with Chronic Kidney Disease.
Topics: Animals; Betaine; Body Composition; Cats; Dietary Supplements; Metabolome; Renal Insufficiency, Chro | 2023 |
8 other studies available for betaine and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Feeding cats with chronic kidney disease food supplemented with betaine and prebiotics increases total body mass and reduces uremic toxins.
Topics: Animals; Betaine; Body Weight; Cats; Cross-Over Studies; Feces; Prebiotics; Renal Insufficiency, Chr | 2022 |
A generalized covariate-adjusted top-scoring pair algorithm with applications to diabetic kidney disease stage classification in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Topics: Algorithms; Betaine; Diabetes Mellitus; Diabetic Nephropathies; Humans; Metabolomics; Renal Insuffic | 2023 |
Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
Topics: Adult; Betaine; Choline; Creatinine; Female; Gastrointestinal Microbiome; Glomerular Filtration Rate | 2019 |
Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.
Topics: Betaine; Biomarkers; Carnitine; Choline; Female; Glomerular Filtration Rate; Humans; Kidney; Male; M | 2021 |
Insights in the regulation of trimetylamine N-oxide production using a comparative biomimetic approach suggest a metabolic switch in hibernating bears.
Topics: Adult; Aged; Aged, 80 and over; Animals; Betaine; Biomimetics; Cardiovascular Diseases; Choline; Fem | 2020 |
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
Topics: Adult; Aged; Animals; Betaine; Carnitine; Case-Control Studies; Choline; Clostridiaceae; Dysbiosis; | 2017 |
Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function.
Topics: Adult; Aged; Aged, 80 and over; Betaine; Biomarkers; Creatinine; Female; Glomerular Filtration Rate; | 2019 |
Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Topics: Adult; Aged; Betaine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Choline; Female; Fibr | 2016 |